← Eichor
Study identifier: NCT07387185 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

AI System for Detection and Characterization of Chronic Enteropathies

Condition: Celiac Disease · Small Bowel Mucosal Atrophy or Lesions · Non-celiac Enteropathies  ·  Sponsor: Istituti Clinici Scientifici Maugeri SpA

PhaseN/A
Planned participants380
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small bowel mucosal atrophy and other pathological findings using endoscopic imaging. The study involves a retrospective phase for training the AI model and a prospective phase to validate its diagnostic accuracy compared to standard human assessment.

This description comes directly from the study's public registry record.

Talk to the study team

Federico Biagi, MD  ·  0382592695  ·  federico.biagi@icsmaugeri.it

Always discuss trial participation with your own doctor first.

Locations (1)

ICS Maugeri IRCCSPavia, PV, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07387185